Precigen (PGEN) Operating Leases (2019 - 2026)
Precigen (PGEN) posted quarterly Operating Leases of $4.7 million for Q1 2026, down 12.66% year-over-year from $5.4 million in Q1 2025, and up 18.87% quarter-over-quarter from $4.0 million in Q4 2025.
Precigen (PGEN) Operating Leases (2019 - 2026) Analysis & Trends
Precigen (PGEN) has reported Operating Leases for 8 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 12.66% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (down 12.66% YoY), while the FY2025 annual figure was $4.0 million, down 12.45% from the prior year.
- Operating Leases rose to $4.7 million in Q1 2026 per PGEN's latest filing, from $4.0 million in the prior quarter.
- Across five years, Operating Leases topped out at $9.5 million in Q1 2022 and bottomed at $4.0 million in Q4 2025.
- Historically, Operating Leases has averaged $6.2 million across 5 years, with a median of $6.3 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Leases soared 36.94% — and 2025, when it tumbled 33.4%.
- Precigen's Operating Leases stood at $7.0 million in 2022, then dropped by 15.69% to $5.9 million in 2023, then decreased by 22.88% to $4.5 million in 2024, then decreased by 12.45% to $4.0 million in 2025, then increased by 18.87% to $4.7 million in 2026.
- Business Quant data shows PGEN's Operating Leases at $4.7 million in Q1 2026, $4.0 million in Q4 2025, and $4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.47 Mn |
| Mar 31, 2026 | 4.73 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 4.18 Mn |
| Jun 30, 2025 | 4.22 Mn |
| Mar 31, 2025 | 5.42 Mn |
| Dec 31, 2024 | 4.55 Mn |
| Sep 30, 2024 | 5.75 Mn |
| Jun 30, 2024 | 6.34 Mn |
| Mar 31, 2024 | 6.71 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 7.39 Mn |
| Jun 30, 2023 | 6.55 Mn |
| Mar 31, 2023 | 6.62 Mn |
| Dec 31, 2022 | 6.99 Mn |
| Sep 30, 2022 | 8.98 Mn |
| Jun 30, 2022 | 8.10 Mn |
| Mar 31, 2022 | 9.51 Mn |
| Dec 31, 2021 | 8.75 Mn |
| Sep 30, 2021 | 11.20 Mn |